Index RUT
P/E -
EPS (ttm) -1.64
Insider Own 36.44%
Shs Outstand 29.44M
Perf Week -4.92%
Market Cap 827.56M
Forward P/E -
EPS next Y -0.84
Insider Trans -0.22%
Shs Float 19.02M
Perf Month -17.49%
Income -48.68M
PEG -
EPS next Q -0.32
Inst Own 46.53%
Short Float / Ratio 3.14% / 2.86
Perf Quarter -25.59%
Sales 307.38M
P/S 2.69
EPS this Y -
Inst Trans 1.28%
Short Interest 0.60M
Perf Half Y -11.15%
Book/sh 42.11
P/B 0.66
EPS next Y 11.52%
ROA -3.46%
Target Price 45.00
Perf Year -27.67%
Cash/sh 15.32
P/C 1.81
EPS next 5Y 15.14%
ROE -3.80%
52W Range 27.30 - 44.09
Perf YTD -7.15%
Dividend -
P/FCF 21.91
EPS past 5Y -
ROI -3.83%
52W High -37.29%
Beta 1.56
Dividend % -
Quick Ratio 8.15
Sales past 5Y 272.11%
Gross Margin 29.45%
52W Low 1.28%
ATR 0.87
Employees 1012
Current Ratio 8.15
Sales Q/Q -45.87%
Oper. Margin -26.27%
RSI (14) 19.10
Volatility 2.67% 2.50%
Optionable Yes
Debt/Eq 0.02
EPS Q/Q -
Profit Margin -15.84%
Rel Volume 0.92
Prev Close 27.32
Shortable Yes
LT Debt/Eq 0.01
Earnings Aug 04 BMO
Payout 0.00%
Avg Volume 208.89K
Price 27.65
Recom 2.00
SMA20 -10.25%
SMA50 -19.40%
SMA200 -18.07%
Volume 191,874
Change 1.21%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-08-22 Downgrade
Piper Sandler
Overweight → Neutral
$65 → $40
Nov-18-22 Initiated
Raymond James
Outperform
$45
Aug-25-22 Initiated
Credit Suisse
Outperform
$65
Feb-04-22 Resumed
Piper Sandler
Overweight
$80
Aug-05-21 Resumed
Credit Suisse
Underperform
$55
Jan-08-21 Downgrade
Credit Suisse
Neutral → Underperform
$42 → $40
Nov-24-20 Downgrade
BTIG Research
Buy → Neutral
Aug-20-20 Initiated
Oppenheimer
Outperform
$75
May-29-20 Initiated
BTIG Research
Buy
$20
Nov-05-19 Upgrade
Piper Jaffray
Neutral → Overweight
Mar-01-18 Downgrade
Piper Jaffray
Overweight → Neutral
Nov-07-17 Downgrade
Raymond James
Outperform → Mkt Perform
Show Previous Ratings
Aug-05-23 08:56AM
Aug-04-23 10:08PM
(Thomson Reuters StreetEvents)
08:15AM
07:00AM
Jul-24-23 04:05PM
08:00AM
Loading…
Jul-18-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 11:40AM
Jun-06-23 07:45AM
Jun-05-23 08:30AM
May-23-23 09:53AM
08:20AM
May-18-23 04:05PM
May-08-23 11:15AM
09:40AM
08:15AM
Loading…
May-05-23 08:15AM
07:00AM
Apr-26-23 08:00PM
Apr-20-23 04:05PM
Apr-16-23 02:01PM
Apr-14-23 07:13AM
06:49AM
Apr-12-23 09:40AM
Apr-11-23 08:00AM
Mar-27-23 09:40AM
Mar-24-23 03:54PM
Mar-09-23 09:40AM
Mar-04-23 07:50AM
Mar-03-23 11:17AM
Mar-01-23 10:13AM
(Thomson Reuters StreetEvents)
08:25PM
Loading…
Feb-28-23 08:25PM
04:05PM
04:03PM
Feb-26-23 09:05AM
Feb-23-23 04:05PM
Feb-14-23 04:05PM
Feb-03-23 05:18AM
Jan-03-23 04:05PM
Dec-15-22 08:11AM
Dec-02-22 12:08PM
Nov-24-22 10:30AM
Nov-17-22 04:05PM
Nov-16-22 06:52AM
Nov-09-22 08:02AM
Nov-07-22 05:55PM
04:06PM
04:05PM
Oct-26-22 07:54AM
Oct-25-22 04:03PM
Oct-20-22 04:03PM
Oct-10-22 11:31AM
Aug-26-22 07:22AM
Aug-25-22 12:10PM
Aug-23-22 02:03PM
Aug-06-22 05:00AM
Aug-05-22 06:30AM
Aug-04-22 07:25PM
04:05PM
08:00AM
08:00AM
Jul-25-22 06:15PM
Jul-19-22 08:00AM
Jul-14-22 06:17PM
Jul-11-22 09:46AM
Jul-05-22 08:00AM
Jun-29-22 06:15PM
Jun-21-22 06:15PM
Jun-19-22 09:06AM
Jun-04-22 08:06AM
May-19-22 07:04AM
May-17-22 11:30AM
May-03-22 11:30PM
05:25PM
04:05PM
04:05PM
09:40AM
08:00AM
07:32AM
Apr-28-22 10:15AM
Apr-27-22 12:05PM
Apr-25-22 06:05PM
(American City Business Journals)
08:38AM
Apr-22-22 11:23AM
Apr-18-22 04:05PM
04:03PM
Apr-08-22 07:55AM
Apr-05-22 04:41PM
Mar-18-22 10:23AM
Mar-16-22 10:28AM
Mar-15-22 05:41PM
(American City Business Journals)
Mar-12-22 10:45AM
Mar-08-22 08:00AM
08:00AM
Mar-07-22 08:00AM
Mar-06-22 07:37AM
Feb-24-22 09:00AM
Feb-23-22 11:00PM
04:05PM
04:05PM
Feb-21-22 10:37AM
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Xie Jian President and COO Sep 07 Sale 31.41 1,492 46,861 416,022 Sep 11 04:37 PM Kim Paul CFO and Treasurer Sep 07 Sale 31.41 1,492 46,861 214,061 Sep 11 04:35 PM Gao Hanlin Chief Scientific Officer Sep 07 Sale 31.41 1,041 32,696 912,932 Sep 11 04:34 PM Kim Paul CFO and Treasurer Aug 28 Sale 33.62 10,299 346,297 215,553 Aug 30 04:54 PM Kim Paul CFO and Treasurer Aug 17 Sale 33.88 1,798 60,918 225,852 Aug 21 04:40 PM Xie Jian President and COO Aug 17 Sale 33.88 1,307 44,283 417,514 Aug 21 04:43 PM Gao Hanlin Chief Scientific Officer Aug 17 Sale 33.88 342 11,587 913,973 Aug 21 04:34 PM Xie Jian President and COO Jun 02 Sale 40.30 1,433 57,744 425,794 Jun 06 05:11 PM Kim Paul CFO and Treasurer Jun 02 Sale 40.30 1,403 56,535 228,890 Jun 06 05:09 PM Gao Hanlin Chief Scientific Officer Jun 02 Sale 40.30 1,000 40,296 914,391 Jun 06 05:06 PM Xie Jian President and COO May 17 Sale 35.46 1,320 46,810 427,227 May 19 04:23 PM Kim Paul CFO and Treasurer May 17 Sale 35.46 1,266 44,895 230,293 May 19 04:19 PM Gao Hanlin Chief Scientific Officer May 17 Sale 35.46 345 12,234 915,391 May 19 04:15 PM KIM PAUL CFO and Treasurer Dec 02 Sale 35.33 653 23,070 223,403 Dec 06 04:42 PM Xie Jian President and COO Nov 30 Sale 34.39 685 23,559 430,074 Dec 02 05:07 PM KIM PAUL CFO and Treasurer Nov 16 Sale 35.89 1,796 64,460 224,056 Nov 18 04:13 PM Xie Jian President and COO Nov 16 Sale 35.89 1,306 46,873 430,759 Nov 18 04:20 PM Gao Hanlin Chief Scientific Officer Nov 16 Sale 35.89 342 12,275 906,585 Nov 18 04:12 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite